ストックスクリーナーアプリを入手
0.943
7.41%
0.0658
前日終値:
$0.8772
開ける：
$0.862
24時間の取引高:
91,788
Relative Volume:
0.67
時価総額：
$4.76M
収益：
-
当期純損益:
$-21.13M
株価収益率:
-0.1969
EPS:
-4.79
ネットキャッシュフロー:
$-16.95M
1週間 パフォーマンス:
+15.61%
1か月 パフォーマンス:
+48.24%
6か月 パフォーマンス:
+66.76%
1年 パフォーマンス:
+496.33%
1日の値動き範囲:
$0.852
$0.94
1週間の範囲:
$0.7722
$1.1697
52週間の値動き範囲:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
名前
Matinas Biopharma Holdings Inc
セクター
電話
908-443-1860
住所
1545 Route 206 South, Suite 302, Bedminster, NJ
MTNB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.9344 | 4.39M | 0 | -21.13M | -16.95M | -4.79 |
|
ONC
Beone Medicines Ltd Adr
|
256.85 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
448.20 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2213 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.33 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
497.88 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 再開されました | Piper Sandler | Overweight |
| 2020-01-27 | 開始されました | Piper Sandler | Overweight |
| 2020-01-24 | 開始されました | SunTrust | Buy |
| 2020-01-23 | 開始されました | SunTrust | Buy |
| 2020-01-09 | 開始されました | Aegis Capital | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Matinas Biopharma Holdings Inc (MTNB) 最新ニュース
Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World
Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada
Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks
Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Matinas Biopharma (NYSE:MTNB) Shares Down 2.6% – Here’s What Happened - Defense World
MTNB stock touches 52-week low at $0.48 amid sharp annual decline - Investing.com Australia
MTNB stock touches 52-week low at $0.48 amid sharp annual decline By Investing.com - Investing.com South Africa
Matinas BioPharma secures shareholder nods on key proposals By Investing.com - Investing.com Australia
Matinas BioPharma secures shareholder nods on key proposals - Investing.com
Matinas Biopharma Delays 10-K Filing - TipRanks
Matinas Biopharma (NYSE:MTNB) Shares Down 6.6% – Should You Sell? - Defense World
Matinas BioPharma Chairman Eric Ende Resigns -March 17, 2025 at 05:08 am EDT - MarketScreener
Matinas BioPharma announces board chairman’s departure By Investing.com - Investing.com Australia
Matinas BioPharma announces board chairman’s departure - Investing.com
Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma -March 14, 2025 at 05:48 pm EDT - Marketscreener.com
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Silicon Valley - Financial Content
Matinas Biopharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market SessionArtiva Biotherapeutics (NASDAQ:ARTV) - Benzinga
Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors - Marketscreener.com
Matinas BioPharma Announces Agreement for the Acquisition - GlobeNewswire
Biotech Deal Alert: Matinas BioPharma Lands Critical $3.3M Investment While Strengthening Leadership - StockTitan
Matinas BioPharma announces board member retirement - MSN
Matinas BioPharma announces board member retirement By Investing.com - Investing.com South Africa
Matinas BioPharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Matinas Biopharma Appoints Evelyn D’An as Director and Audit Committee Chair - Armenian Reporter
Matinas BioPharma Appoints Evelyn D’An to Board - citybiz
Matinas BioPharma Holdings, Inc. Appoints Evelyn D?An to Board of Directors as an Independent Director and Chair of the Audit Committee - Marketscreener.com
Matinas Biopharma Appoints Evelyn D'An To Board Of Directors As Audit Committee Chair - Marketscreener.com
Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - The Manila Times
Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair - GlobeNewswire
Matinas BioPharma announces board member resignation - MSN
Matinas BioPharma announces board member resignation By Investing.com - Investing.com South Africa
Matinas Biopharma Holdings, Inc. Announces Resignation of James S. Scibetta from Board and Audit and Compensation Committees - Marketscreener.com
111 Equity Group Increases Stake In Matinas Biopharma Holdings - citybiz
111 Equity ups stake in Matinas Biopharma Holdings - Investing.com
Matinas Biopharma Holdings Inc (MTNB) 財務データ
収益
当期純利益
現金流量
EPS
1.30%
3.35%
大文字化:
|
ボリューム (24 時間):